Ter Veer E, van Rijssen LB, Besselink MG, Mali RMA, Berlin JD, Boeck S, et al. Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease. Lancet Oncol. 2018;19(3):151–60.

Article  Google Scholar 

Moningi S, Lei X, Fang P, Taniguchi CM, Holliday EB, Koay EJ, et al. Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer. Clin Transl Radiat Oncol. 2022;35:9–16.

CAS  PubMed  PubMed Central  Google Scholar 

Andrew O, Mark L, Hien L, George H, Raymond D, David P, et al. Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT). Pract Radiat Oncol. 2020;10(3):136–46.

Article  Google Scholar 

Manisha P, Devon G, Karyn AG, Sarah H, Laura AD, et al. Radiation therapy for pancreatic cancer: executive summary of an ASTRO clinical practice guideline. Pract Radiat Oncol. 2019;9(5):322–32.

Article  Google Scholar 

Scemla R, Shah SM, Schwartz M, Barkin JS. Colonic apple-core lesion resulting from cyberknife treatment of unresectable pancreatic cancer. Pancreas. 2006;32(3):332–3.

Article  PubMed  Google Scholar 

Jung J, Yoon SM, Park JH, Seo DW, Lee SS, Kim MH, et al. Stereotactic body radiation therapy for locally advanced pancreatic cancer. PLoS ONE. 2019;14(4):e0214970.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gondré M, Conrad M, Vallet V, Bourhis J, Bochud F, Moeckli R. Commissioning and validation of RayStation treatment planning system for CyberKnife M6. J Appl Clin Med Phys. 2022;23(8):e13732.

Article  PubMed  PubMed Central  Google Scholar 

Riley C, Cox C, Graham S, Havran H, Kramer B, Netherton T, et al. Varian Halcyon dosimetric comparison for multiarc VMAT prostate and head-and-neck cancers. Med Dosim. 2018;6:S0958-3947.

Google Scholar 

Kurosaki H, Hirayama K, Takahashi M, Uematsu M, Tate E. Tomotherapy: comparison of Hi-ART, Tomo-HD, and Radixact. Cureus. 2022;14(10):e30949.

PubMed  PubMed Central  Google Scholar 

Bertholet J, Hunt A, Dunlop A, Bird T, Mitchell RA, Oelfke U, Nill S, et al. Comparison of the dose escalation potential for two hypofractionated radiotherapy regimens for locally advanced pancreatic cancer. Clin Transl Radiat Oncol. 2019;16:21–7.

PubMed  PubMed Central  Google Scholar 

Ding Y, Campbell WG, Miften M, Vinogradskiy Y, Goodman KA, Schefter T, et al. Quantifying allowable motion to achieve safe dose escalation in pancreatic SBRT. Pract Radiat Oncol. 2019;9(4):e432–42.

Article  PubMed  PubMed Central  Google Scholar 

Hanna GG, Murray L, Patel R, Jain S, Aitken KL, et al. UK consensus on normal tissue dose constraints for stereotactic radiotherapy. Clin Oncol (R Coll Radiol). 2018;30(1):5–14.

Article  CAS  PubMed  Google Scholar 

Tatsiana AR, Andrew RJ, Ellen EB, Mustafa O. Dose gradient index for stereotactic radiosurgery/radiation therapy. Int J Radiat Oncol Biol Phys. 2020;106(3):604–11.

Article  Google Scholar 

Zhu X, Ju X, Cao Y, Shen Y, Cao F, Qing S, et al. Patterns of local failure after stereotactic body radiation therapy and sequential chemotherapy as initial treatment for pancreatic cancer: implications of target volume design. Int J Radiat Oncol Biol Phys. 2019;104(1):101–10.

Article  PubMed  Google Scholar 

Diamant A, Heng VJ, Chatterjee A, Faria S, Bahig H, et al. Comparing local control and distant metastasis in NSCLC patients between cyberknife and conventional SBRT. Radiother Oncol. 2020;144:201–8.

Article  PubMed  Google Scholar 

Kannarunimit D, Descovich M, Garcia A, Chen J, Weinberg V, Mcguinness C, et al. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy. Technol Cancer Res Treat. 2015;14(1):49–60.

Article  CAS  PubMed  Google Scholar 

Chapman KL, Witek ME, Chen H, Showalter TN, Bar-Ad V, Harrison AS. Pancreatic cancer planning: complex conformal vs modulated therapies. Med Dosim. 2016;41(2):100–4.

Article  PubMed  Google Scholar 

Nalichowski A, Kaufman I, Gallo J, Bossenberger T, Solberg T, et al. Single fraction radiosurgery/stereotactic body radiation therapy (SBRT) for spine metastasis: a dosimetric comparison of multiple delivery platforms. J Appl Clin Med Phys. 2017;18(1):164–9.

Article  PubMed  Google Scholar 

Dai ZT, Ma L, Cao TT, Zhu L, Zhao M, et al. Dosimetric and radiobiological comparison of treatment plan between CyberKnife and EDGE in stereotactic body radiotherapy for pancreatic cancer. Sci Rep. 2021;11(1):4065.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar R, Wild AT, Ziegler MA, Hooker TK, Dah SD, Tran PT, et al. Stereotactic body radiation therapy planning with duodenal sparing using volumetric-modulated arc therapy vs intensity-modulated radiation therapy in locally advanced pancreatic cancer: a dosimetric analysis. Med Dosim. 2013;38(3):243–50.

Article  PubMed  PubMed Central  Google Scholar 

de Chavez R, Grogan G, Hug B, Howe K, Grigg A, Waterhouse D, et al. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT. Med Dosim. 2022;47(1):61–9.

Article  PubMed  Google Scholar 

Matthew HG, Katz QS, Jeffrey PM, Joseph MH, Michael C, Brian MW, et al. Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas. J Clin Oncol. 2021;39(3):337.

Google Scholar 

Loi M, Magallon-Baro A, Suker M, van Eijck C, Sharma A, Hoogeman M, et al. Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk. Radiother Oncol. 2019;134:67–73.

Article  PubMed  Google Scholar 

Niedzielski JS, Liu Y, Ng SSW, Martin RM, Perles LA, Beddar S, et al. Dosimetric uncertainties resulting from interfractional anatomic variations for patients receiving pancreas stereotactic body radiation therapy and cone beam computed tomography image guidance. Int J Radiat Oncol Biol Phys. 2021;111(5):1298–309.

Article  PubMed  PubMed Central  Google Scholar